Inventiva S.A. (IVEVF)
Data as of Nov 2, 4:00 PM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
IVEVF key stats
IVEVF GlowScore: Quiet
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Inventiva S.A.
INVENTIVA SA ACT PORTEUR
What's moving IVEVF today
Updated November 3, 2026As of November 3, 2026, Inventiva S.A. (IVEVF) stock is trading at $3.18, roughly flat versus the previous close. That puts IVEVF near the bottom of its 52-week range of $3.18 to $5.75. Inventiva S.A. carries a market capitalization of roughly $751.18 million, with about 100 shares changing hands.
Latest IVEVF news
- Inventiva (IVA) vs. CRSP and MDGL: Can Lanifibranor’s Phase 3 Trial Unlock 62% Upside?Yahoo Finance· Oct 28, 9:13 AM ETIVA
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Aheadmarketbeat.com· Oct 10, 10:35 AM ET
- Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026Yahoo Finance· Oct 6, 4:05 PM ET
- Inventiva (IVA): How Much Is One Make-or-Break Readout Really Worth?Yahoo Finance· Oct 4, 3:26 PM ETIVA
- Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Testmarketbeat.com· Oct 4, 1:02 AM ETIVA
- European Equities Traded in the US as American Depositary Receipts Lower in Tuesday TradingYahoo Finance· Sep 29, 11:07 AM ET
- Inventiva (IVA) Q2 2026 Earnings Call Transcriptfool.com· Sep 29, 10:00 AM ETIVA
- Inventiva SA (IVEVF) (H1 2026) Earnings Call Highlights: Lanifibranor Nears Phase 3 Readout ...Yahoo Finance· Sep 28, 3:00 PM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want IVEVF headlines, alerts and AI research in one place? Create a free account →
IVEVF Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on IVEVF
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.